Objective: To describe a refined technique for performing electrical impedance myography (EIM) in the rat and assess its reproducibility, long-term stability, and the effects of sciatic nerve injury. Methods: EIM at 50 kHz was performed on the gastrocnemius-soleus complex of the rat hind limb in 12 rats, followed from 6 weeks of age for up to 6 months. Eight additional rats underwent sciatic nerve crush and 6 underwent a sham procedure. Results: The EIM variables of resistance, reactance and phase demonstrated substantial change with growth until approximately 14 weeks of age, at which point the measurements stabilized, giving mean values of 6.0 ± 5.7 X, 22.1 ± 2.1 X, and 16.5 ± 1.1°, respectively, at 16 weeks of age. Immediate reproducibility of technique was high with an intraclass correlation coefficient of 0.91 and higher for all three parameters. Sciatic crush produced marked reductions in the reactance and phase that reversed over a several week period. Conclusions: These results support that 50 kHz EIM can be performed effectively in adult rat models of neuromuscular disease with a straightforward experimental technique and that it is sensitive to neurogenic injury. Significance: EIM can serve as a new approach to the study of neuromuscular disease in the rat.
Introduction
Electrical impedance myography (EIM) is a neurophysiologic technique in which high-frequency, low-intensity electrical current is applied via surface electrodes over a muscle or muscle group of interest and the resulting voltage patterns analyzed. (Shiffman et al., 1999; Rutkove et al., 2002) . Unlike conventional neurophysiologic methods, such as needle electromyography or nerve conduction studies, EIM does not rely overtly upon the inherent electrophysiologic activity of the muscle, but rather on changes in the composition and structure of the muscle that accompany neuromuscular disease. Such alterations can be detected when applying EIM to human subjects with a variety of conditions including amyotrophic lateral sclerosis, inflammatory myopathy, and radiculopathy (Rutkove et al., 2005 (Rutkove et al., , 2007 Tarulli et al., 2005) . These changes in the EIM signature can be used to assess neuromuscular disease status and thus to track a disease's progression or remission, making EIM potentially useful in clinical therapeutic trials or in individual patient care (Rutkove et al., 2005 (Rutkove et al., , 2007 Tarulli et al., 2005) . In addition, by specifically assessing the directionality of current flow through a muscle, EIM can also assist in discriminating neurogenic from myopathic disease (Garmirian et al., 2009) . A review article providing a comprehensive background on the technique and its potential applications is also available (Rutkove, in press).
To date, we have mainly applied the EIM techniques to human subjects. However, it is clear that in order to reach a deeper understanding of the mechanisms underlying electrical impedance change in neuromuscular disorders, it is critical that we begin to apply EIM systematically to animal models of disease. This is especially true since disease heterogeneity in human subjects substantially limits our ability to model effectively the observed impedance data. Moreover, studying animal models also gives us the opportunity to evaluate directly the ways in which EIM data relates to muscle pathology -something that would be difficult to achieve in human subjects. Finally, establishing a straightforward methodology would allow others to utilize EIM in animal studies, for example, as a biomarker or outcome measure in preclinical drug studies. Several years ago we completed a small study assessing the feasibility of these measurements in rats (Nie et al., 2006) . In this study, we build upon that earlier work by describing in detail a refined methodology for performing EIM on the rat hind limb, assessing its reproducibility, the effects of growth, and changes observed with sciatic nerve injury and recovery.
